Protara Therapeutics | 4:持股變動聲明-董事 Flannelly Barry P
Protara Therapeutics | 4:持股變動聲明-董事 Smith Cynthia
Protara Therapeutics | 4:持股變動聲明-董事 Solomon Michael Edward
Protara Therapeutics | 4:持股變動聲明-董事 SARGEN GREGORY
Protara Therapeutics | 4:持股變動聲明-董事 Levy Richard S
Protara Therapeutics | 4:持股變動聲明-董事 Huang Jane
Protara Therapeutics | 4:持股變動聲明-董事 GARCEAU ROGER
Protara Therapeutics | 4:持股變動聲明-董事 BESHAR LUKE M
Protara Therapeutics | 8-K:重大事件
Protara Therapeutics | 4:持股變動聲明-股東 Opaleye Management Inc.
Protara Therapeutics | 4:持股變動聲明-股東 Opaleye Management Inc.
Protara Therapeutics | 4:持股變動聲明-股東 Opaleye Management Inc.
Protara Therapeutics | 4:持股變動聲明-股東 Opaleye Management Inc.
Protara Therapeutics | EFFECT:其他
Protara Therapeutics | 424B3:募資說明書
Protara Therapeutics | CORRESP:信函
Protara Therapeutics | UPLOAD:其他
Protara Therapeutics | S-3:特定交易註冊聲明
Protara Therapeutics | 10-Q:季度報表
Protara Therapeutics | 8-K:Protara Therapeutics公佈2024年第一季度財務業績並提供業務最新情況
暫無數據